Trials / Completed
CompletedNCT06823076
Impact of the COVID-19 Pandemic on Central Precocious Puberty: a Retrospective Cohort Study from Turkey
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 192 (actual)
- Sponsor
- Umraniye Education and Research Hospital · Other Government
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Objective: This study investigates the clinical and demographic characteristics of girls diagnosed with central precocious puberty (CPP) in the pre-pandemic and pandemic periods to assess potential changes during the COVID-19 pandemic.
Detailed description
Methods: A retrospective cohort study was conducted on patients admitted to the Pediatric Endocrinology Departments of two centers in Turkey. Girls treated with GnRH analogs between March 2018 and 2022 were categorized into two groups: the pre-pandemic group (2018-2020) and the pandemic group (2020-2022). Clinical, anthropometric, and hormonal data were analyzed. Patients with organic lesions, genetic conditions, or medications affecting puberty were excluded.
Conditions
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2022-03-01
- Completion
- 2023-03-01
- First posted
- 2025-02-12
- Last updated
- 2025-02-12
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06823076. Inclusion in this directory is not an endorsement.